Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy

Annals of Thoracic Surgery

Volumn 86, Issue 2, 2008, Pages 376-382

  Gudbjartsson, Tomas ^a   Gyllstedt, Erik ^a   Pikwer, Andreas ^a   Jönsson, Per ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CARBOPLATIN; CISPLATIN; DIGOXIN; MITOMYCIN; PACLITAXEL; VINBLASTINE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; BRONCHOPLEURA FISTULA; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE DURATION; EMPYEMA; FEMALE; HAZARD RATIO; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIPLE CYCLE TREATMENT; PNEUMONIA; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PREOPERATIVE RADIOTHERAPY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RECURRENT LARYNGEAL NERVE PALSY; REOPERATION; RESPIRATORY FAILURE; RISK ASSESSMENT; SEPSIS; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVAL TIME; SYMPTOM; WOUND INFECTION;

AGED; BRONCHIAL FISTULA; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LENGTH OF STAY; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PLEURAL DISEASES; PNEUMONECTOMY; POSTOPERATIVE COMPLICATIONS; RESPIRATORY TRACT FISTULA; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 47149099209     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2008.04.013     Document Type: Article

References (38)

1. Albain K.S., Crowley J.J., Turrisi III A.T., et al. Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019. J Clin Oncol 20 (2002) 3454-3460
2. Rusch V.W., Giroux D.J., Kraut M.J., et al. Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: initial results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Thorac Cardiovasc Surg 121 (2001) 472-483
3. Stamatis G., Djuric D., Eberhardt W., et al. Postoperative morbidity and mortality after induction chemoradiotherapy for locally advanced lung cancer: an analysis of 350 operated patients. Eur J Cardiothorac Surg 22 (2002) 292-297
4. Albain K.S., Rusch V.W., Crowley J.J., et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 13 (1995) 1880-1892
5. Doddoli C., Barlesi F., Trousse D., et al. One hundred consecutive pneumonectomies after induction therapy for non-small cell lung cancer: an uncertain balance between risks and benefits. J Thorac Cardiovasc Surg 130 (2005) 416-425
6. Martini J., Ginsberg R.J., Abolhoda A., et al. Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy. Ann Thorac Surg 72 (2001) 1149-1154
7. Roberts J.R., Eustis C., Devore R., Carbone D., Choy H., and Johnson D. Induction chemotherapy increases perioperative complications in patients undergoing resection for non-small cell lung cancer. Ann Thorac Surg 72 (2001) 885-888
8. Sonett J.R., Suntharalingam M., Edelman M.J., et al. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer. Ann Thorac Surg 78 (2004) 1200-1205 discussion 1206
9. Deutsch M., Crawford J., Leopold K., et al. Phase II study of neoadjuvant chemotherapy and radiation therapy with thoracotomy in the treatment of clinically staged IIIA non-small cell lung cancer. Cancer 74 (1994) 1243-1252
10. Fowler W.C., Langer C.J., Curran Jr. W.J., and Keller S.M. Postoperative complications after combined neoadjuvant treatment of lung cancer. Ann Thorac Surg 55 (1993) 986-989
11. Barlesi F., Doddoli C., Torre J.P., et al. Comparative prognostic features of stage IIIAN2 and IIIB non-small-cell lung cancer patients treated with surgery after induction therapy. Eur J Cardiothorac Surg 28 (2005) 629-634
12. Nagai K., Tsuchiya R., Mori T., et al. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209). J Thorac Cardiovasc Surg 125 (2003) 254-260
13. Perrot E., Guibert B., Mulsant P., et al. Preoperative chemotherapy does not increase complications after nonsmall cell lung cancer resection. Ann Thorac Surg 80 (2005) 423-427
14. Port J.L., Korst R.J., Lee P.C., et al. Surgical resection for residual N2 disease after induction chemotherapy. Ann Thorac Surg 79 (2005) 1686-1690
15. Siegenthaler M.P., Pisters K.M., Merriman K.W., et al. Preoperative chemotherapy for lung cancer does not increase surgical morbidity. Ann Thorac Surg 71 (2001) 1105-1111 discussion 1111-2
16. Van Schil P., Van Meerbeeck J., Kramer G., et al. Morbidity and mortality in the surgery arm of EORTC 08941 trial. Eur Respir J 26 (2005) 192-197
17. Brambilla E., Travis W.D., Colby T.V., Corrin B., and Shimosato Y. The new World Health Organization classification of lung tumours. Eur Respir J 18 (2001) 1059-1068
18. Ginsberg R.J., Hill L.D., Eagan R.T., et al. Modern thirty-day operative mortality for surgical resections in lung cancer. J Thorac Cardiovasc Surg 86 (1983) 654-658
19. Harpole D.H., Liptay M.J., DeCamp Jr. M.M., Mentzer S.J., Swanson S.J., and Sugarbaker D.J. Prospective analysis of pneumonectomy: risk factors for major morbidity and cardiac dysrhythmias. Ann Thorac Surg 61 (1996) 977-982
20. Swartz D.E., Lachapelle K., Sampalis J., Mulder D.S., Chiu R.C., and Wilson J. Perioperative mortality after pneumonectomy: analysis of risk factors and review of the literature. Can J Surg 40 (1997) 437-444
21. Cerfolio R.J., Bryant A.S., Spencer S.A., and Bartolucci A.A. Pulmonary resection after high-dose and low-dose chest irradiation. Ann Thorac Surg 80 (2005) 1224-1230 discussion 1230
22. Daly B.D., Fernando H.C., Ketchedjian A., et al. Pneumonectomy after high-dose radiation and concurrent chemotherapy for nonsmall cell lung cancer. Ann Thorac Surg 82 (2006) 227-231
23. Mansour Z., Kochetkova E.A., Ducrocq X., et al. Induction chemotherapy does not increase the operative risk of pneumonectomy!. Eur J Cardiothorac Surg 31 (2007) 181-185
24. Matsubara Y., Takeda S., and Mashimo T. Risk stratification for lung cancer surgery: impact of induction therapy and extended resection. Chest 128 (2005) 3519-3525
25. Vora S.A., Daly B.D., Blaszkowsky L., et al. High dose radiation therapy and chemotherapy as induction treatment for stage III nonsmall cell lung carcinoma. Cancer 89 (2000) 1946-1952
26. Rosell R., Gomez-Codina J., Camps C., et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med 330 (1994) 153-158
27. Roth J.A., Fossella F., Komaki R., et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst 86 (1994) 673-680
28. Depierre A., Milleron B., Moro-Sibilot D., et al. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer. J Clin Oncol 20 (2002) 247-253
29. Bueno R., Richards W.G., Swanson S.J., et al. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival. Ann Thorac Surg 70 (2000) 1826-1831
30. Alexiou C., Beggs D., Rogers M.L., Beggs L., Asopa S., and Salama F.D. Pneumonectomy for non-small cell lung cancer: predictors of operative mortality and survival. Eur J Cardiothorac Surg 20 (2001) 476-480
31. Wahi R., McMurtrey M.J., DeCaro L.F., et al. Determinants of perioperative morbidity and mortality after pneumonectomy. Ann Thorac Surg 48 (1989) 33-37
32. Bernard A., Deschamps C., Allen M.S., et al. Pneumonectomy for malignant disease: factors affecting early morbidity and mortality. J Thorac Cardiovasc Surg 121 (2001) 1076-1082
33. Licker M., Spiliopoulos A., Frey J.G., et al. Risk factors for early mortality and major complications following pneumonectomy for non-small cell carcinoma of the lung. Chest 121 (2002) 1890-1897
34. Sfyridis P.G., Kapetanakis E.I., Baltayiannis N.E., et al. Bronchial stump buttressing with an intercostal muscle flap in diabetic patients. Ann Thorac Surg 84 (2007) 967-971
35. Ramnath N., Demmy T.L., Antun A., et al. Pneumonectomy for bronchogenic carcinoma: analysis of factors predicting survival. Ann Thorac Surg 83 (2007) 1831-1836
36. Socinski M.A. The current status of adjuvant chemotherapy for resected non-small cell lung cancer. Semin Oncol 26 5 suppl 15 (1999) 27-33
37. Robinson L.A., Ruckdeschel J.C., Wagner Jr. H., and Stevens C.W. Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132 3 auppl (2007) 243S-265S
38. Ma Z., Dong A., Fan J., and Cheng H. Does sleeve lobectomy concomitant with or without pulmonary artery reconstruction (double sleeve) have favorable results for non-small cell lung cancer compared with pneumonectomy?. A meta-analysis. Eur J Cardiothorac Surg 32 (2007) 20-28